18315-81-6

Basic information

• Product Name: Benzene, [(1Z)-2-bromo-2-nitroethenyl]-
• CAS NO: 18315-81-6
• Molecular Formula: C8H6BrNO2
• Molecular Weight: 228.045
• Mol File: 18315-81-6.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: Benzene, [(1Z)-2-bromo-2-nitroethenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, [(1Z)-2-bromo-2-nitroethenyl]-(18315-81-6)
• EPA Substance Registry System: Benzene, [(1Z)-2-bromo-2-nitroethenyl]-(18315-81-6)

Safety Data

• Hazardous Substances Data: 18315-81-6(Hazardous Substances Data)

Upstream product

• 563-70-2 bromonitromethane 
• 100-52-7 benzaldehyde 
• 3425-99-8 (1,2-dibromo-2-nitroethyl)benzene 
• 5153-67-3 nitrostyrene 
• 102-96-5 (2-nitroethenyl)benzene 
• 22013-79-2 1-(4-chlorophenyl)-1,2-dibromo-2-nitroethane 
• 344319-06-8 N-(2-bromo-2-nitro-1-phenyl-ethyl)-p-toluidine 
• 7732-18-5 water 
• 67-66-3 chloroform 
• 7726-95-6 bromine 
• 1077-18-5 N-benzylidenebutan-1-amine 
• 103-64-0 bromostyrene 

Downstream Products

• 7166-19-0 beta-bromo-beta-nitrostyrene 
• 344319-06-8 N-(2-bromo-2-nitro-1-phenyl-ethyl)-p-toluidine 
• 14645-81-9 1-Brom-1,3-dinitro-2-phenyl-pentan 
• 112616-84-9 2-(2-bromo-2-nitro-1-phenyethan-1-yl)pyrrole 
• 99290-11-6 ((4S,5R)-3-Bromo-2-oxy-4-phenyl-4,5-dihydro-isoxazol-5-yl)-phenyl-methanone 
• 1215-07-2 (E)-(1-nitroethene-1,2-diyl)dibenzene 
• 108695-61-0 1-methyl-4-[(E)-1-nitro-2-phenylvinyl]benzene 

Relevant articles and documents

Organocatalytic Asymmetric Synthesis of Aza-Spirooxindoles via Michael/Friedel-Crafts Cascade Reaction of 1,3-Nitroenynes and 3-Pyrrolyloxindoles

An asymmetric [3+3] cyclization of nitroenynes and 3-pyrrolyloxindoles has been realized with a chiral bifunctional squaramide catalyst. This Michael/Friedel-Crafts cascade strategy provides a facile and efficient access to enantioenriched polycyclic aza-spirooxindoles with 32-95% isolated yields and excellent stereocontrol under mild reaction conditions.

Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells

The implication of DNA methylation in cancer is today clearly established. Despite that nucleoside analogues are currently used for leukaemia treatment, their low stability in physiological conditions and their lack of selectivity arise the need for the i

Novel synthesis scheme and in vitro antimicrobial evaluation of a panel of (E)-2-aryl-1-cyano-1-nitroethenes

Drug resistance has become a major concern in the field of infection management, therefore searching for new antibacterial agents is getting more challenging. Our study presents an optimized and eco-friendly synthesis scheme for a panel of nitroalkenes be